BB vs ZYME
BlackBerry Ltd (BB) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
BlackBerry Ltd (BB) is a software - infrastructure company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported BB revenue for 2026-02-28 was $549.1M. Net income was $53.2M. Revenue was up 2.7% from 2025-02-28 to 2026-02-28. BB currently screens at market cap $6.14B and trailing P/E 116.5.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
BB currently screens at market cap $6.14B and trailing P/E 116.5. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the BB and ZYME stock pages for the full models.
Not investment advice.